Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sweetenham, J. W.
Right arrow Articles by Whitehouse, J. M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sweetenham, J. W.
Right arrow Articles by Whitehouse, J. M. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 3:839-841, 1992
© 1992 European Society for Medical Oncology

research-article

Adult lymphoblastic lymphoma: High incidence of central nervous system relapse in patients treated with the Stanford University protocol

J. W. Sweetenham, G. M. Mead and J. M. A. Whitehouse

CRC Wessex Medical Oncology Unit, University of Southampton, Southampton General Hospital Southampton, United Kingdom

J. W. Sweetenham, Bsc DM MRCP CRC Wessex Medical Oncology Unit University of Southampton Southampton General Hospital Tremona Road Southampton SO9 4XY United Kingdom

Twelve adult patients with non-leukaemic lymphoblastic lymphoma were treated with combination chemotherapy and central nervous system prophylaxis according to the protocol developed at Stanford University. Despite strict adherence to the Stanford protocol, 4 of 12 patients relapsed in the CNS, all with meningeal disease. Only four of the 12 patients are in continuing complete remission 6 to 88 months from the completion of induction therapy. These results are inferior to those previously reported for this regimen, and fail to confirm the high rate of control of CNS disease.

lymphoblastic lymphoma, chemotherapy, CNS, relapse


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.